Form 4: Eastman Chemical Co: CFO William Thomas McLain Jr. Reports Stock Transactions
SEC Form 4 Filing
Eastman Chemical Co's CFO, William Thomas McLain Jr., reports the acquisition and disposal of company stock and stock options.
Summary
- William Thomas McLain Jr., the EVP and CFO of Eastman Chemical Co, filed a Form 4 detailing changes in beneficial ownership.
- On February 21, 2025, McLain exercised employee stock options to acquire 1,963 shares of common stock at a price of $74.46.
- Simultaneously, McLain disposed of 1,963 shares of common stock at a price of $101.
- McLain also acquired 28,919 employee stock options with an exercise price of $100.56 on February 20, 2025, which become exercisable in thirds starting February 20, 2026.
- Additionally, McLain acquired 5,523 restricted stock units on February 20, 2025, which will vest on February 20, 2028, subject to continued employment.
- Following these transactions, McLain beneficially owns 49,854 shares of common stock, 28,919 employee stock options (at $100.56), and 5,523 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The document does not contain explicit forward-looking statements, but it outlines the vesting schedule for stock options and restricted stock units, indicating future compensation and ownership changes.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and potential alignment with shareholder interests. These filings are common across all publicly traded companies.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Eastman Chemical (EMN).
- Companies such as Dow (DOW), BASF (BAS), and LyondellBasell (LYB) also utilize similar equity-based compensation to align executive incentives with shareholder value.
- The vesting schedules and exercise prices are generally in line with industry norms for executive compensation plans.
- The specific amounts and terms, however, vary based on company size, performance, and individual executive agreements.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly diluting equity.
- Employees holding similar stock options and restricted stock units may be interested in the vesting schedules and exercise prices.
- The transactions do not directly impact customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/27/2018 | Date related to employee stock option. |
| 02/20/2025 | Date of employee stock option and restricted stock unit acquisition. |
| 02/21/2025 | Date of common stock acquisition and disposal. |
| 02/24/2025 | Date of signature on the form. |
| 02/26/2025 | Date related to employee stock option. |
| 02/20/2026 | First vesting date for one-third of the acquired employee stock options. |
| 02/20/2027 | Second vesting date for one-third of the acquired employee stock options. |
| 02/20/2028 | Final vesting date for one-third of the acquired employee stock options and vesting date for restricted stock units. |
| 02/19/2035 | Expiration date for employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.